Elevated Liver Enzymes along with Comorbidity Is a High Risk Factor for COVID-19 Mortality: A South Indian Study on 1,512 Patients

BACKGROUND AND AIMS: Liver enzyme abnormalities in coronavirus 2019 (COVID-19) are being addressed in the literature. The predictive risk of elevated liver enzymes has not been established for COVID-19 mortality. In this study, we hypothesized that elevated liver enzymes at admission can predict the...

Descripción completa

Detalles Bibliográficos
Autores principales: Krishnasamy, Narayanasamy, Rajendran, Karthick, Barua, Parimita, Ramachandran, Arunkumar, Panneerselvam, Priyadarshini, Rajaram, Muthukumaran
Formato: Online Artículo Texto
Lenguaje:English
Publicado: XIA & HE Publishing Inc. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845151/
https://www.ncbi.nlm.nih.gov/pubmed/35233380
http://dx.doi.org/10.14218/JCTH.2020.00100

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8845151/
https://www.ncbi.nlm.nih.gov/pubmed/35233380
http://dx.doi.org/10.14218/JCTH.2020.00100

Ejemplares similares